Inflammatory Signal Inhibitors for COVID-19 (MATIS)

Clinical trial NCT04581954 · COMPLETED

Trial details

NCT number: NCT04581954
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronavirus Covid19 Pneumonia

Start date: 2020-10-02
Primary completion: 2022-11-30
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.